LOGIN
Bisphosphonate treatment maintains positive effect on bone loss at 6 year follow-up
April 2013
Bisphosphonate treatment maintains positive effect on bone loss at 6 year follow-up
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Changes of femoral periprosthetic bone mineral density 6 years after treatment with alendronate following total hip arthroplasty
J Orthop Res. 2009 Feb;27(2):183-8Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
49 patients who had undergone total hip arthroplasty (THA) were randomized to a postoperative bisphosphonate (oral alendronate) treatment group or to a non-treatment group, to assess the effect of bisphosphonate on bone mineral density (BMD) and bone loss. Results from this study indicated that there was a significant increase in BMD from the 1-year to the 6-year follow up in Gruen region 5 of the...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.